Comments
Loading...

Repligen

RGENNASDAQ
Logo brought to you by Benzinga Data
$139.00
-3.03-2.13%
Pre-Market: 4:26 PM EDT
15 minutes delayed

Financials

Quarterly
Annual
Name
Revenue
Change
Gross
Change
EBITDA
Change
EBIT
Change
Earnings
Change
Analyst Trends and Forecast
1
May
1
Jun
3
Jul
1
Aug
Buy
Hold
Sell
Strong Sell
Analyst Rating and Forecast
12345
4.4
Buy
Strong Buy
Buy
Hold
Sell
Strong Sell
About Repligen Corp.
Sector
Health Care
Industry
Life Sciences Tools & Services
Repligen Corp is a global life sciences company. It develops and commercializes innovative bioproces...
Show More

Compare

EPS worse than industry
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
RGEN
MEDP

FAQ

Q

How do I buy Repligen (RGEN) stock?

A

You can purchase shares of Repligen (NASDAQ:RGEN) through any online brokerage.

View our list of the best stock brokerages

Q

Who are Repligen (RGEN) competitors?

Q

What is the forecast, or price target, for Repligen (RGEN) stock?

A

Repligen has a consensus price target of $201.83.

Q

What is the current price for Repligen (RGEN)?

A

The stock price for Repligen (NASDAQ: RGEN) is $139 last updated September 18, 2024 at 4:26 PM EDT.

Q

Does Repligen (RGEN) pay a dividend?

A

There are no upcoming dividends for Repligen.

Q

When is Repligen (NASDAQ:RGEN) reporting earnings?

A

Repligen’s Q3 earnings are confirmed for Tuesday, October 29, 2024.

Q

Is Repligen (RGEN) going to split?

A

There is no upcoming split for Repligen.

Q

What sector and industry does Repligen (RGEN) operate in?

A

Repligen is in the Health Care sector and Life Sciences Tools & Services industry. They are listed on the NASDAQ.

People Also Watch